On June 25, 2018, Lalique Group SA completed its listing on SIX Swiss Exchange (ticker symbol: LLQ / ISIN CH0033813293). Together with the switch of the listing from BX Swiss to the SIX Swiss Exchange, the company issued 1,000,000 new shares in a rights offering. The opening price of the shares was CHF 51, which leads to a market capitalization of Lalique Group SA of CHF 306 million.
The new shares were created in an ordinary capital increase approved by the ordinary annual general meeting of Lalique Group SA on 8 June 2018. Within the rights offering, the existing shareholders received subscription rights, entitling them to subscribe for one new share in Lalique Group SA for every five shares held at an offer price of CHF 30, which corresponds to a discount of approximately 40% compared to the opening price of the shares on SIX Swiss Exchange. The capital increase is intended to further strengthen the group’s balance sheet and included a conversion of shareholder loans of the majority shareholder in an amount of CHF 21.6 million into equity. Delivery of the new shares against payment of the subscription price took place on June 25, 2018. Bank Vontobel AG acted as sole bookrunner in the transaction.
Lalique Group is a niche player in the creation, development, marketing and global distribution of luxury goods. Its business areas comprise perfumes, cosmetics, crystal, jewelry, high-end furniture and living accessories, along with art, gastronomy and hospitality. Founded in 2000, the company employs approx. 600 staff and has its headquarters in Zurich. The Lalique brand, from which the Group derives its name, was created in Paris in 1888 by the master glassmaker and jewelry designer René Lalique.
Baker McKenzie acted as legal counsel to Lalique Group SA in connection with the capital increase and the listing on SIX Swiss Exchange. The Baker McKenzie team was led by Dr. Matthias Courvoisier (Partner, Capital Markets) and Martin Frey (Partner, Corporate/M&A) and comprised Dr. Philip Spoerlé (Associate, Capital Markets), Dr. Salome Jibuti (Associate, Capital Markets) and Susanne Liebel-Kotz (Associate, Tax).